F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to:1. Remove 16 doses of morphine sulfate (a
medication used to treat pain) 15 milligrams (mg - a unit of measure for mass) and 56 doses of
oxycodone/APAP (a medication used to treat pain) 5/325 mg from the medication cart after the physician's
orders were discontinued affecting two of three sampled residents (Residents 1 and 3.)2. Create a
Controlled Drug Administration Record (a log signed by the nurse with the date and time each time a
controlled substance is given to a resident) for one of two supplies of oxycodone (a medication used to treat
pain) 5 mg affecting one of three sampled residents (Resident 2.) The deficient practices of failing to
maintain accountability of controlled substances (medications with a high risk for abuse) increased the risk
of diversion (any use other than that intended by the prescriber) and the risk that Residents 1, 2 and 3
could have received too much or too little medication possibly resulting in serious health complications
requiring hospitalization. Findings: During an observation and concurrent interview of Medication Cart 2 on
10/28/25 at 1:02 p.m. with the Licensed Vocational Nurse (LVN)1 the following supplies of controlled
medications were found in the medication cart:1. Thirteen doses of morphine sulfate 15 mg for Resident 12.
Fifty-six doses of oxycodone/APAP 5 mg for Resident 3 A review of Resident 1's Controlled Drug
Administration Record indicated three doses of morphine sulfate had been removed from the supply and
administered to Resident 1 on 10/22/2025 at 12:00 a.m. and 6:00 a.m., and on 10/27/2025 at 6:00 a.m. A
review of Resident 1's Controlled Drug Administration Record and pharmacy label on the medication supply
indicated the instructions for use were morphine sulfate 15 mg by mouth every eight (8) hours as needed
for severe pain and 1/2 tablet by mouth every eight (8) hours as needed for moderate pain. A review of
Resident 1's admission Record (a record containing diagnostic and demographic resident information),
dated 10/28/2025, the admission record indicated the resident was originally admitted to the facility on
[DATE] with diagnoses including prostate cancer and collapsed vertebrae. A review of Resident 1's undated
History and Physical (a record of a physician's comprehensive medical examination) did not indicate
whether he had the capacity to understand and make medical decisions. A review of Resident 1's Order
Audit Report (a report outlining a timeline of a physician's order), dated 10/28/2025, the order audit report
indicated on 10/20/2025, Resident 1 was prescribed morphine sulfate 15 mg by mouth every eight (8)
hours as needed for severe pain and 1/2 tablet by mouth every eight (8) hours as needed for moderate
pain. Further review of the Order Audit Report indicated this physician order was discontinued on
10/21/2025. A review of Resident 3's Controlled Drug Administration Record and pharmacy label indicated
the instructions for use were oxycodone/APAP 5/325 by mouth every four hours as needed for pain. Further
review of the pharmacy label indicated the date of dispensing was 10/2/2025. A review of Resident 3's
admission Record, dated 10/28/2025, the admission record indicated the resident was originally admitted to
the facility on [DATE] with diagnoses including heart failure and swelling in
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
055192
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055192
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Providence St Elizabeth Care Center
10425 Magnolia Blvd
North Hollywood, CA 91601
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
the lungs. A review of Resident 3's History and Physical, dated 10/3/2025, the history and physical
indicated she had the capacity to understand and make medical decisions. A review of Resident 3's Order
Audit Report, dated 10/28/2025, the order audit report indicated on 10/2/2025, Resident 2 was prescribed
oxycodone/APAP 5/325 to take one tablet by mouth every four hours as needed for pain. Further review of
the Order Audit Report indicated this physician order was discontinued on 10/2/2025. During a concurrent
interview with LVN 1, LVN 1 stated when controlled medications are discontinued, they should be
immediately removed from the medication cart and surrendered to the Director of Nursing (DON) for safe,
secure storage. LVN 1 stated the nurse or nurses receiving the discontinue orders for Resident 1's
morphine and Resident 3's oxycodone/APAP failed to remove the corresponding medication supply from
the medication cart. LVN 1 stated having discontinued controlled medications in the cart causes confusion
for nursing staff and can lead to medication errors possibly resulting in overdose of narcotics leading to
potentially serious medical complications. During an observation and concurrent interview of Medication
Cart 1 on 10/28/2025 at 1:27 p.m. with the Licensed Vocational Nurse (LVN) 2 the following supplies of
controlled medications were found in the medication cart:1. Fifteen tablets of oxycodone five mg for
Resident 2 with instructions on the pharmacy label to take one tablet via gastrostomy tube (g-tube - a tube
surgically implanted into the stomach for the administration of medication and nutrition) twice daily2. Thirty
tablets of oxycodone five mg for Resident 2 with instructions on the pharmacy label to take one tablet via
g-tube every one hour as needed for pain A review of Resident 2's Controlled Drug Administration Records
indicated there were two records matching the instructions to take one tablet via g-tube every one hour as
needed for pain and no records corresponding to the supply labeled with instructions to take one tablet via
g-tube twice daily. A review of Resident 2's admission Record, dated 10/28/2025, the admission record
indicated she was originally admitted to the facility on [DATE], with diagnoses hemiplegia and hemiparesis
following cerebral infarction affecting right dominant side (right side weakness or paralysis following a
stroke.) A review of Resident 2's History and Physical, dated 10/17/2025, the history and physical indicated
she did not have the capacity to understand and make medical decisions. A review of Resident 2's Order
Summary Report (a summary of all active physician orders), dated 10/28/2025, the order summary report
indicated she had active physician orders for the following:1. Oxycodone five mg via g-tube two times a day
for pain management2. Oxycodone five mg via g-tube every one hour as needed for pain. During a
concurrent interview with LVN 2, LVN 2 stated there is no additional Controlled Drug Administration Record
for Resident 2 corresponding to the twice daily scheduled dosage. LVN 2 stated the Controlled Drug
Administration Record for Resident 2's oxycodone appears to have been created incorrectly. LVN 2 stated,
instead of two different records for the scheduled and the PRN (as needed) supplies, the controlled drug
record for the PRN supply was likely duplicated by mistake. LVN 2 stated this error was likely caused by the
dispensing pharmacy who supplied the medications as they created the Controlled Drug Administration
Records for the facility. LVN 2 stated the facility staff failed to notice this error when they received these
medications from the pharmacy and thus have been documenting the administration of Resident 2's
oxycodone incorrectly. LVN 2 stated there is risk of diversion or possibly overdose to Resident 2 because
her supply of oxycodone is not being accurately accounted for. During an interview with the Director of
nursing (DON) on 10/28/2025 at 2:41 p.m., the DON stated the facility failed to remove the discontinued
supplies of morphine for Resident 1 and oxycodone/APAP for Resident 3 from Medication Cart 2. The DON
stated the facility failed to ensure there was a Controlled Drug Administration Record created that matched
the info for Resident 2's scheduled oxycodone. The DON stated there were two accountability records
created, but they
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055192
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055192
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Providence St Elizabeth Care Center
10425 Magnolia Blvd
North Hollywood, CA 91601
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
contained the same prescription information, indicating one of Resident 2's supplies of oxycodone could not
be accurately accounted for. The DON stated the failure to maintain accountability of controlled substances
by failing to remove discontinued medication from the cart and failure to maintain a controlled drug
accountability record increased the risk for diversion of controlled substances and also increased the risk
that Residents 1, 2 and 3 could have received pain medication outside of the prescribed schedule, possibly
leading to medical complications. A review of the facility's policy Discontinued Medications, dated May
2022, the policy indicated Medications are removed from the medication cart or active supply immediately
upon receipt of an order to discontinue (to avoid inadvertent administration. A review of the facility's policy
Controlled Medication - Storage and Reconciliation. Last revised June 2025, the policy indicated A
controlled medication accountability record is prepared by authorized individuals when receiving or
checking in a Schedule II, III, IV, or V (controlled) medication.
Event ID:
Facility ID:
055192
If continuation sheet
Page 3 of 3